Published in J Pediatr on March 15, 2010
Early outcomes and prognostic factors for left atrioventricular valve reoperation after primary atrioventricular septal defect repair. Pediatr Cardiol (2011) 1.43
Racial/ethnic differences in survival of United States children with birth defects: a population-based study. J Pediatr (2015) 1.15
Surgical management of complete atrioventricular septal defect: associations with surgical technique, age, and trisomy 21. J Thorac Cardiovasc Surg (2010) 0.96
Role of health insurance on the survival of infants with congenital heart defects. Am J Public Health (2014) 0.87
Community socioeconomic disadvantage and the survival of infants with congenital heart defects. Am J Public Health (2014) 0.82
Atrioventricular septal defect prognosis for patients with Down syndrome. Pediatr Cardiol (2012) 0.80
Databases for Congenital Heart Defect Public Health Studies Across the Lifespan. J Am Heart Assoc (2016) 0.75
Long-Term Survival of Individuals Born With Congenital Heart Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc (2016) 0.75
Repair of complete atrioventricular septal defect in infants with down syndrome: outcomes and long-term results. Pediatr Cardiol (2014) 0.75
Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol (2010) 7.00
Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med (2014) 6.12
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr (2008) 3.87
Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol (2007) 3.29
A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol (2007) 2.69
A review of the literature on the effects of ambient air pollution on fetal growth. Environ Res (2004) 2.49
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med (2012) 2.35
Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation (2010) 2.26
The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young (2008) 1.92
Maternal exposure to methotrexate and birth defects: a population-based study. Am J Med Genet A (2014) 1.70
The National Children's Study of environmental effects on child health and development. Environ Health Perspect (2003) 1.68
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics (2009) 1.66
Children's health and the environment: public health issues and challenges for risk assessment. Environ Health Perspect (2004) 1.61
The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res A Clin Mol Teratol (2003) 1.58
Ambient air pollution and preterm birth: a time-series analysis. Epidemiology (2009) 1.57
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Ambient air pollution and cardiovascular malformations in Atlanta, Georgia, 1986-2003. Am J Epidemiol (2009) 1.54
Florida health care providers' knowledge of folic acid for the prevention of neural tube defects. South Med J (2004) 1.51
Quantifying geocode location error using GIS methods. Environ Health (2007) 1.48
Temporal trends in survival among infants with critical congenital heart defects. Pediatrics (2013) 1.45
Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics (2010) 1.43
Variation in prevalence of gestational diabetes mellitus among hospital discharges for obstetric delivery across 23 states in the United States. Diabetes Care (2012) 1.43
International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ (2005) 1.39
Does screening in the emergency department hurt or help victims of intimate partner violence? Ann Emerg Med (2008) 1.39
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
FRIL: A tool for comparative record linkage. AMIA Annu Symp Proc (2008) 1.38
Conjoined twins: a worldwide collaborative epidemiological study of the International Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet C Semin Med Genet (2011) 1.37
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. Birth Defects Res A Clin Mol Teratol (2006) 1.34
Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program. Birth Defects Res A Clin Mol Teratol (2007) 1.32
Gastroschisis and associated defects: an international study. Am J Med Genet A (2007) 1.30
Seasonality of birth and implications for temporal studies of preterm birth. Epidemiology (2009) 1.28
Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics (2011) 1.28
Non-genetic risk factors for gastroschisis. Am J Med Genet C Semin Med Genet (2008) 1.26
The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol (2011) 1.24
Residential mobility during pregnancy: patterns and correlates. Matern Child Health J (2009) 1.23
Lexicon, definitions, and conceptual framework for public health surveillance. MMWR Surveill Summ (2012) 1.20
Frequency of holoprosencephaly in the International Clearinghouse Birth Defects Surveillance Systems: searching for population variations. Birth Defects Res A Clin Mol Teratol (2008) 1.18
Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. Am J Med Genet A (2011) 1.17
Prenatal diagnosis, pregnancy terminations and prevalence of Down syndrome in Atlanta. Birth Defects Res A Clin Mol Teratol (2004) 1.16
Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection? Birth Defects Res A Clin Mol Teratol (2013) 1.15
Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998. J Pediatr (2006) 1.14
Sensitivity of birth certificate reports of birth defects in Atlanta, 1995-2005: effects of maternal, infant, and hospital characteristics. Public Health Rep (2011) 1.13
Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol (2007) 1.13
Setting a public health research agenda for Down syndrome: summary of a meeting sponsored by the Centers for Disease Control and Prevention and the National Down Syndrome Society. Am J Med Genet A (2008) 1.13
Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005. Birth Defects Res A Clin Mol Teratol (2013) 1.13
Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol (2009) 1.12
Indoor charcoal smoke and acute respiratory infections in young children in the Dominican Republic. Am J Epidemiol (2009) 1.11
Intent to become pregnant as a predictor of exposures during pregnancy: is there a relation? J Reprod Med (2005) 1.11
Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions. Birth Defects Res A Clin Mol Teratol (2013) 1.10
Promoting pre-conceptional use of folic acid to Hispanic women: a social marketing approach. Matern Child Health J (2006) 1.08
Use of spline regression in an analysis of maternal prepregnancy body mass index and adverse birth outcomes: does it tell us more than we already know? Ann Epidemiol (2008) 1.08
Public health science agenda for congenital heart defects: report from a Centers for Disease Control and Prevention experts meeting. J Am Heart Assoc (2013) 1.07
Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy. Am J Med Sci (2007) 1.07
Inter-rater reliability of assessed prenatal maternal occupational exposures to solvents, polycyclic aromatic hydrocarbons, and heavy metals. J Occup Environ Hyg (2011) 1.06
Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol (2006) 1.06
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease. Circ Res (2017) 1.06
Methods for detecting functional classifications in neuroimaging data. Hum Brain Mapp (2004) 1.05
Association between congenital heart defects and small for gestational age. Pediatrics (2007) 1.04
Are encephaloceles neural tube defects? Pediatrics (2006) 1.01
Factors associated with late detection of critical congenital heart disease in newborns. Pediatrics (2013) 1.01
Risk factors for non-syndromic holoprosencephaly in the National Birth Defects Prevention Study. Am J Med Genet C Semin Med Genet (2010) 1.01
Epidemiology of gastroschisis in metropolitan Atlanta, 1968 through 2000. Birth Defects Res A Clin Mol Teratol (2005) 1.00
Maternal exposure to criteria air pollutants and congenital heart defects in offspring: results from the national birth defects prevention study. Environ Health Perspect (2014) 1.00
Priorities for public health research on craniosynostosis: summary and recommendations from a Centers for Disease Control and Prevention-sponsored meeting. Am J Med Genet A (2008) 0.98
Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects. Birth Defects Res A Clin Mol Teratol (2004) 0.98
Trends in survival among children with Down syndrome in 10 regions of the United States. Pediatrics (2012) 0.98
Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study. AIDS Res Hum Retroviruses (2013) 0.97
Racial/ethnic variations in the prevalence of selected major birth defects, metropolitan Atlanta, 1994-2005. Public Health Rep (2012) 0.97
An update on cardiovascular malformations in congenital rubella syndrome. Birth Defects Res A Clin Mol Teratol (2010) 0.97
Biomonitoring of four European populations occupationally exposed to pesticides: use of micronuclei as biomarkers. Mutagenesis (2003) 0.97
Sirenomelia: an epidemiologic study in a large dataset from the International Clearinghouse of Birth Defects Surveillance and Research, and literature review. Am J Med Genet C Semin Med Genet (2011) 0.96
Trihalomethane exposures from municipal water supplies and selected congenital malformations. Epidemiology (2003) 0.96
Health supervision for children with Turner syndrome. Pediatrics (2003) 0.96